Treatment of Patients With Recently Exacerbated Schizophrenia With Paliperidone Palmitate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01448720
Recruitment Status : Completed
First Posted : October 7, 2011
Last Update Posted : September 18, 2014
Information provided by (Responsible Party):
Janssen-Cilag Farmaceutica Ltda.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : December 2013
  Actual Study Completion Date : December 2013